Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway

BACKGROUND: Non small cell lung cancer (NSCLC) is one of the most common cancers in the world. DHA is known to be capable of suppressing NSCLC cell proliferation and metastasis. However, the mechanisms by which DHA exhibits its antitumor effects are unknown. Here we aimed to identify the effects and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xiaoming, Shao, Jiaofang, Zhou, Sujin, Zhao, Zhenggang, Li, Fanghong, Xiang, Rong, Zhao, Allan Z., Pan, Jinshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884860/
https://www.ncbi.nlm.nih.gov/pubmed/31783879
http://dx.doi.org/10.1186/s13046-019-1478-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884860/
https://www.ncbi.nlm.nih.gov/pubmed/31783879
http://dx.doi.org/10.1186/s13046-019-1478-3

Ejemplares similares